You searched for "ocular pathology"
Extraocular muscle BT after ocular pathology
1 June 2014
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
Management is described for 13 patients who received inferior rectus botulinum toxin (BT) injection for vertical strabismus due to orbital pathology. Patients were aged 19-86 years, eight were female and seven were right eye injections. Orbital pathology included six with...
The David J Apple International Laboratory for Ocular Pathology – a legacy of pioneering IOL research
David Apple and Gerd Auffarth. The Apple Lab at the David J Apple Center for Vision Research in Heidelberg is a thriving international laboratory for research into intraocular devices. The lab continues the work of David J Apple, a world-renowned...
Using a tumour registry to investigate optic nerve gliomas
31 October 2023
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
This study is a retrospective comparative analysis. Patients with optic nerve glioma and pilocytic astrocytoma were identified through the Surveillance, Epidemiology and End Results (SEER) cancer registry covering a 42-year period using standardised codes. The following data was extracted: basic...
Severe conjunctival cicatrisation secondary to chronic glaucoma therapy
1 August 2015
| Mrinal Rana, AK Negi
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
The timing of glaucoma filteration surgery during the course of chronic progressive glaucoma remains a contentious issue amongst glaucoma specialists. The vast majority support the use of maximal medical treatment initially to achieve the target pressure. Surgical procedures are only...
Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)
3 April 2023
| Li Yen Goh
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...
Immunoglobulin G4-related ophthalmic disease – what is it? (Part 1)
3 February 2023
| Li Yen Goh
|
EYE - General
Part 1: Epidemiology, classification, radiology, histopathology and associations (see Part 2 here) In this two-part series, Li Yen Goh reviews IgG4 disease and reminds us of diagnostic challenges faced. Introduction Immunoglobulin G4 (IgG4) disease is a recently recognised idiopathic systemic...
Stem cell transplantation and pterygium surgery
28 November 2022
| Aina Pons, Abhinav Loomba
|
EYE - General
Pterygium is a benign, fibrovascular overgrowth of bulbar conjunctiva extending onto the cornea and has been associated with ultraviolet (UV) light exposure. The prevalence of pterygium worldwide varies between geographical zones but has been reported to range between three and...
Diary from my elective: a Parisian experience
2 December 2019
| Nikolaos Tzoumas
|
EYE - General
The author explains how a research institute’s dedication to multidisciplinary collaboration helped him to discover a passion for academic ophthalmology. The elective aspect to the final year of a medical degree, through its change of scenery and immersion into another...
